Secukinumab retreatment associated psoriasis flare with pustules.
Plaque psoriasis
paradoxical psoriasis
psoriatic arthritis
secukinumab
Journal
The Journal of dermatological treatment
ISSN: 1471-1753
Titre abrégé: J Dermatolog Treat
Pays: England
ID NLM: 8918133
Informations de publication
Date de publication:
Mar 2022
Mar 2022
Historique:
pubmed:
17
6
2020
medline:
8
4
2022
entrez:
16
6
2020
Statut:
ppublish
Résumé
This case report describes a patient with plaque psoriasis and psoriatic arthritis who experienced IL-17A blocking antibody secukinumab treatment-interruption followed by re-treatment. The patient showed heterogeneous responses; significant improvement at initial introduction of secukinumab with rapid deterioration after discontinuation, followed by worsening symptoms and pustular eruption with reintroduction, and skin clearance after dose escalation.
Identifiants
pubmed: 32538223
doi: 10.1080/09546634.2020.1782816
doi:
Substances chimiques
Antibodies, Monoclonal, Humanized
0
secukinumab
DLG4EML025
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM